JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB13597

Anti-TNFAIP3 antibody [59A426]

3

(1 리뷰)

|

(41 제품이 사용된 논문 )

Mouse Monoclonal TNFAIP3 antibody. Suitable for WB, IHC-P, Flow Cyt (Intra) and reacts with Human samples. Cited in 41 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human TNFAIP3.

대체 명칭 보기

OTUD7C, TNFAIP3, Tumor necrosis factor alpha-induced protein 3, TNF alpha-induced protein 3, OTU domain-containing protein 7C, Putative DNA-binding protein A20, Zinc finger protein A20

6 이미지
Flow Cytometry (Intracellular) - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-TNFAIP3 antibody [59A426] (AB13597)

Overlay histogram showing HepG2 cells stained with ab13597 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab13597, 2μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a decreased signal in HepG2 cells fixed with methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [59A426] (AB13597)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human placenta tissue labelling TNFAIP3 with ab13597 at 5μg/ml. Staining was enhanced by boiling tissue sections in 10mM sodium citrate buffer, pH6.0 for 10-20 minutes followed by cooling at room temperature for 20 minutes.

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • WB

Lab

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)

Lanes 1-4 : Merged signal (red and green). Green - ab13597 observed at 80 kDa. Red - loading control, ab181602 observed at 37 kDa.

ab13597 Anti-TNFAIP3 antibody [59A426] was shown to specifically react with TNFAIP3 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265983 (knockout cell lysate ab257112) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab13597 and Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-TNFAIP3 antibody [59A426] (ab13597) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

TNFAIP3 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human TNFAIP3 knockout HeLa cell line (<a href='/ko/products/cell-lines/human-tnfaip3-knockout-hela-cell-line-ab265983'>ab265983</a>)

Lane 3:

Jurkat cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate at 20 µg

Lane 4:

Untreated Jurkat cell lysate at 20 µg

Predicted band size: 89 kDa

Observed band size: 80 kDa

false

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • WB

Supplier Data

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)

Lanes 1-4 : Merged signal (red and green). Green - ab13597 observed at 80 kDa. Red - loading control, ab181602 observed at 37 kDa.

ab13597 Anti-TNFAIP3 antibody [59A426] was shown to specifically react with TNFAIP3 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265983 (knockout cell lysate ab257112) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab13597 and Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-TNFAIP3 antibody [59A426] (ab13597) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

TNFAIP3 knockout HeLa cell lysate at 20 µg

Lane 3:

Jurkat cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate at 20 µg

Lane 4:

Untreated Jurkat cell lysate at 20 µg

Predicted band size: 89 kDa

Observed band size: 80 kDa

false

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • WB

Supplier Data

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)

All lanes:

Western blot - Anti-TNFAIP3 antibody [59A426] (ab13597) at 4 µg/mL

All lanes:

Jurkat cell lysate

Predicted band size: 89 kDa

false

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)
  • WB

Unknown

Western blot - Anti-TNFAIP3 antibody [59A426] (AB13597)

All lanes:

Western blot - Anti-TNFAIP3 antibody [59A426] (ab13597) at 1 µg/mL

Lane 1:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Lane 2:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/ko/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution

Predicted band size: 89 kDa

Observed band size: 15 kDa,34 kDa,90 kDa

true

Exposure time: 20min

주요 정보

Host species

Mouse

Clonality

Monoclonal

Clone number

59A426

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, Flow Cyt (Intra)

applications

Immunogen

Recombinant Full Length Protein corresponding to Human TNFAIP3.

P21580

Epitope

The epitope has been mapped to the C-terminal portion of A20, amino acids 440-790.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2-4 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1-2 µg/cells for 6 µg/cells", "FlowCytIntra-species-notes": "<p><a href='/ko/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein G
보관 버퍼
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11 : BCL10 : MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerized macrophages.
See full target information TNFAIP3

제품이 사용된 논문 (41)

Recent publications for all applications. Explore the 전체 목록 and refine your search

JCI insight 8: PubMed36633909

2023

A20 and the noncanonical NF-κB pathway are key regulators of neutrophil recruitment during fetal ontogeny.

Applications

Unspecified application

Species

Unspecified reactive species

Ina Rohwedder,Lou Martha Wackerbarth,Kristina Heinig,Annamaria Ballweg,Johannes Altstätter,Myriam Ripphahn,Claudia Nussbaum,Melanie Salvermoser,Susanne Bierschenk,Tobias Straub,Matthias Gunzer,Marc Schmidt-Supprian,Thomas Kolben,Christian Schulz,Averil Ma,Barbara Walzog,Matthias Heinig,Markus Sperandio

Respiratory research 24:50 PubMed36788604

2023

Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.

Applications

Unspecified application

Species

Unspecified reactive species

Xuefeng Xu,Fei Zheng,Shanshan Xu,Minfei Hu,Chengcheng Hang,Lingke Liu,Chencong Shen,Weizhong Gu,Lizhong Du

Journal of periodontal research 57:1183-1197 PubMed36146901

2022

Canonical and noncanonical pyroptosis are both activated in periodontal inflammation and bone resorption.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Zhang,Zhiwu Wu,Mingming Li,Jin Yang,Ran Cheng,Tao Hu

Evidence-based complementary and alternative medicine : eCAM 2022:2836880 PubMed35432558

2022

Effects of Ruanmailing in Blocking Early Stages of Atherosclerosis by TNF- Regulation via Kir2.1.

Applications

Unspecified application

Species

Unspecified reactive species

Liufang Fan,Xuanbin Huang,Wenjuan Xue,Weyan Xie,Ruxi Tong,Jinshui Chen,Tianmin Wu

Bioengineered 12:9902-9913 PubMed34895052

2021

MicroRNA miR-27b-3p regulate microglial inflammation response and cell apoptosis by inhibiting A20 (TNF-α-induced protein 3).

Applications

Unspecified application

Species

Unspecified reactive species

Liping Li,Chao Qi,Yuanyuan Liu,Youliang Shen,Xia Zhao,Han Qin,Yi Zhang,Tengbo Yu

Frontiers in immunology 12:623256 PubMed34381441

2021

A20 Establishes Negative Feedback With TRAF6/NF-κB and Attenuates Early Brain Injury After Experimental Subarachnoid Hemorrhage.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Ji Deng,QuZhen Deji,WangDui Zhaba,Jia-Qiang Liu,Sheng-Qing Gao,Yan-Ling Han,Meng-Liang Zhou,Chun-Xi Wang

Experimental and therapeutic medicine 21:364 PubMed33732337

2021

MSK1 downregulation is involved in inflammatory responses following subarachnoid hemorrhage in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Bo Ning,Zhen Li,Lei Ning,Jun Wu,Xin Chen,Pengjun Jiang,Fuxin Lin,Bing Zhao

Journal of immunology research 2020:3230490 PubMed32377532

2020

Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Naren Bao,Bing Tang,Junke Wang

Nature communications 11:1211 PubMed32139701

2020

Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Ji,Lihong Zhou,Hua Sui,Liu Yang,Xinnan Wu,Qing Song,Ru Jia,Ruixiao Li,Jian Sun,Ziyuan Wang,Ningning Liu,Yuanyuan Feng,Xiaoting Sun,Gang Cai,Yu Feng,Jianfeng Cai,Yihai Cao,Guoxiang Cai,Yan Wang,Qi Li

JCI insight 4: PubMed31581152

2019

A20 as an immune tolerance factor can determine islet transplant outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Nathan W Zammit,Stacey N Walters,Karen L Seeberger,Philip J O'Connell,Gregory S Korbutt,Shane T Grey
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com